• TRADE NAMES: Antispaz; Bemote; Bentyl (Aptalis); Bentylol; Byclomine; Di-Spaz; Dibent; Formulex; Lomine; Merbentyl; Neoquess; Notensyl; OrTyl; Panakiron; Spasmoban; Spasmoject; Swityl
  • INDICATIONS: Irritable bowel syndrome
  • CLASS: Anticholinergic, Muscarinic antagonist
  • HALF-LIFE: initial: 1.8 hours; terminal: 9–10 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Antacids, Anticholinergics, Antiglaucoma agents, Arbutamine

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric